Supplemental Figure 1 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas
| Autor: | Helena A. Yu, Franziska Michor, Gregory J. Riely, Mark G. Kris, Marc Ladanyi, Paul K. Paik, Andrew J. Plodkowski, Sara A. Hayes, Afsheen N. Iqbal, Isabel R. Preeshagul, Linda S. Ahn, Khadeja A. Moses, Alex Makhnin, Arielle Elkrief |
|---|---|
| Rok vydání: | 2023 |
| Popis: | Supplemental Figure 1. Dose modifications of Combination Osimertinib and Dacomitinib (initial therapy study). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|